AU3191397A - Oxazolone derivatives and their use as anti-(helicobacter pylori) agent - Google Patents
Oxazolone derivatives and their use as anti-(helicobacter pylori) agentInfo
- Publication number
- AU3191397A AU3191397A AU31913/97A AU3191397A AU3191397A AU 3191397 A AU3191397 A AU 3191397A AU 31913/97 A AU31913/97 A AU 31913/97A AU 3191397 A AU3191397 A AU 3191397A AU 3191397 A AU3191397 A AU 3191397A
- Authority
- AU
- Australia
- Prior art keywords
- agent
- helicobacter pylori
- oxazolone derivatives
- oxazolone
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8-164854 | 1996-06-25 | ||
| JP16485496 | 1996-06-25 | ||
| JP2516297 | 1997-02-07 | ||
| JP9-25162 | 1997-02-07 | ||
| PCT/JP1997/002157 WO1997049703A2 (en) | 1996-06-25 | 1997-06-24 | Oxazolone derivatives and their use as anti-helicobacter pylori agents |
| ZA978876A ZA978876B (en) | 1996-06-25 | 1997-10-03 | Oxazolone derivatives and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3191397A true AU3191397A (en) | 1998-01-14 |
Family
ID=27284916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU31913/97A Abandoned AU3191397A (en) | 1996-06-25 | 1997-06-24 | Oxazolone derivatives and their use as anti-(helicobacter pylori) agent |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0923577A2 (zh) |
| CN (1) | CN1077892C (zh) |
| AU (1) | AU3191397A (zh) |
| CA (1) | CA2248784A1 (zh) |
| WO (1) | WO1997049703A2 (zh) |
| ZA (1) | ZA978876B (zh) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6387687B1 (en) * | 1998-07-30 | 2002-05-14 | Takeda Chemical Industries, Ltd. | Process for producing indolmycin |
| DK1222922T3 (da) | 1999-10-20 | 2007-12-03 | Eisai R&D Man Co Ltd | Fremgangsmåde til stabilisering af benzimidazolforbindelser |
| CA2550361C (en) | 2003-12-19 | 2014-04-29 | Prabha Ibrahim | Compounds and methods for development of ret modulators |
| US7498342B2 (en) | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
| GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
| US7371862B2 (en) | 2005-11-11 | 2008-05-13 | Pfizer Italia S.R.L. | Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
| EP2170830B1 (en) | 2007-07-17 | 2014-10-15 | Plexxikon, Inc. | 2-FLUORO-BENZENESULFONAMIDE COMPOUNDS AS Raf KINASE MODULATORS |
| MY172424A (en) | 2009-04-03 | 2019-11-25 | Hoffmann La Roche | Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof |
| BR112012012156A2 (pt) | 2009-11-06 | 2015-09-08 | Plexxikon Inc | compostos e métodos para modulação de cinase, e indicações para esta |
| TR201816421T4 (tr) | 2011-02-07 | 2018-11-21 | Plexxikon Inc | Kinaz modülasyonu için bileşikler ve metotlar ve bunların endikasyonları. |
| AR085279A1 (es) | 2011-02-21 | 2013-09-18 | Plexxikon Inc | Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico |
| AU2012255275B2 (en) | 2011-05-17 | 2016-01-28 | Plexxikon Inc. | Kinase modulation and indications therefor |
| US9358235B2 (en) | 2012-03-19 | 2016-06-07 | Plexxikon Inc. | Kinase modulation, and indications therefor |
| US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| CN114945569A (zh) * | 2019-12-26 | 2022-08-26 | 延世大学校产学协力团 | 吡咯烷衍生物，以及包含其的用于预防或治疗β-淀粉样蛋白或Tau蛋白相关疾病的药物组合物 |
| CN113480544B (zh) * | 2021-07-09 | 2022-04-26 | 成都大学 | 一种炔基化咪唑并[1,5-a]吲哚化合物及制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US458385A (en) * | 1891-08-25 | Heater | ||
| GB862685A (en) * | 1956-11-02 | 1961-03-15 | Pfizer & Co C | New antibiotic designated pa 155a |
| US3173923A (en) * | 1961-04-13 | 1965-03-16 | Pfizer & Co C | 1-(3'-indolyl)-1-[5"-(2''-methylimino)-4''-ketooxazolidinyl] ethane and acid addition salts thereof |
| US3320282A (en) * | 1962-10-29 | 1967-05-16 | Pfizer & Co C | Process for preparing esters of 2-hydroxy-3-(3-indolyl) alkanoic acids |
| US4584385A (en) * | 1984-03-22 | 1986-04-22 | Pfizer Inc. | Antibacterial 2-amino-oxazolinones and process therefor |
| US5607932A (en) * | 1994-07-12 | 1997-03-04 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of azolones |
-
1997
- 1997-06-24 WO PCT/JP1997/002157 patent/WO1997049703A2/en not_active Application Discontinuation
- 1997-06-24 EP EP97927428A patent/EP0923577A2/en not_active Withdrawn
- 1997-06-24 CN CN97195506A patent/CN1077892C/zh not_active Expired - Fee Related
- 1997-06-24 CA CA002248784A patent/CA2248784A1/en not_active Abandoned
- 1997-06-24 AU AU31913/97A patent/AU3191397A/en not_active Abandoned
- 1997-10-03 ZA ZA978876A patent/ZA978876B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA978876B (en) | 1999-06-30 |
| WO1997049703A3 (en) | 1998-02-26 |
| WO1997049703A2 (en) | 1997-12-31 |
| CA2248784A1 (en) | 1997-12-31 |
| EP0923577A2 (en) | 1999-06-23 |
| CN1230958A (zh) | 1999-10-06 |
| CN1077892C (zh) | 2002-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7243398A (en) | Cross-platform computer architecture and components thereof | |
| AU3191397A (en) | Oxazolone derivatives and their use as anti-(helicobacter pylori) agent | |
| AU2103097A (en) | Cinnoline derivatives and use as medicine | |
| AU7718898A (en) | Txu-7-pap immunotoxin and use thereof | |
| AU1987697A (en) | Packed-add and packed subtract operations | |
| AU2896597A (en) | Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides | |
| AU2875297A (en) | N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use | |
| AU2769697A (en) | Benzofuryl derivatives and their use | |
| ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
| AU1136297A (en) | Methods and compositions for diagnosis of hyperhomocysteinemia | |
| AU3352197A (en) | Pyridyl-piperazinyl-phenyl-oxazolidinone derivatives and their use as antibacterials | |
| AU2972597A (en) | Compositions and uses thereof | |
| AU3472799A (en) | Dermatological formulations and methods | |
| AU2670897A (en) | Fibulin pharmaceutical compositions and related methods | |
| AU2126495A (en) | Recombinase-deficient (helicobacter pylori) and related methods | |
| AU2664797A (en) | Wnt receptor compositions and methods | |
| AU2932197A (en) | Benzothiophenes, formulations containing same, and methods | |
| AU2215497A (en) | Benzothiophenes, formulations containing same, and methods | |
| AU3048297A (en) | Granular hydrating agent | |
| AU5160596A (en) | Helicobacter pylori cagi region | |
| AU3073297A (en) | Curable topcoat composition and methods for use | |
| AU2894997A (en) | Mercapto-imidazolyl derivatives and their use as microbicides | |
| AU1572297A (en) | Monoglyceride compositions and their use against helicobacter | |
| AU1698899A (en) | N-acetylserotonin derivatives and uses thereof | |
| ZA9711047B (en) | Formulation and use. |